个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共10条记录  
  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
    [作者:Fornari, F; Gramantieri, L; Ferracin, M; Veronese, A; Sabbioni, S; Calin, GA; Grazi, GL; Giovannini, C; Croce, CM; Bolondi, L; Negrini, M,期刊:Oncogene, 页码:5651-5661 , 文章类型: Article,,卷期:2008年27-43]
  • The identification of target mRNAs is a key step for assessing the role of aberrantly expressed microRNAs in human cancer. MiR-221 is upregulated in human hepatocellular carcinoma (HCC) as well as in other malignancies. ...
  • DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function
    [作者:Britschgi, A; Trinh, E; Rizzi, M; Jenal, M; Ress, A; Tobler, A; Fey, MF; Helin, K; Tschan, MP,期刊:Oncogene, 页码:5706-5716 , 文章类型: Article,,卷期:2008年27-43]
  • Death-associated protein kinase 2 (DAPK2) belongs to a family of proapoptotic Ca2+/calmodulin-regulated serine/threonine kinases. We recently identified DAPK2 as an enhancing factor during granulocytic differentiation. T...
  • Constitutively active Rheb induces oncogenic transformation
    [作者:Jiang, H; Vogt, PK,期刊:Oncogene, 页码:5729-5740 , 文章类型: Article,,卷期:2008年27-43]
  • Rheb (Ras-homolog enriched in brain) is a component of the phosphatidylinositol 3-kinase (PI3K) target of rapamycin (TOR) signa ling pathway, functioning as a positive regulator of TOR. Constitutively active mutants of R...
  • LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
    [作者:Stutz, MA; Shattuck, DL; Laederich, MB; Carraway, KL; Sweeney, C,期刊:Oncogene, 页码:5741-5752 , 文章类型: Article,,卷期:2008年27-43]
  • Epidermal growth factor receptor (EGFR) mutation is frequently observed in human cancer and contributes to the growth, survival and therapeutic resistance of tumors. EGFRvIII is an oncogenic EGFR mutant resulting from th...